0023

CN:BLUESAIL

蓝帆医疗

  • Stock

CNY

Last Close

5.37

25/11 07:04

Market Cap

4.46B

Beta: -

Volume Today

7.53M

Avg: -

Company Overview

Metric
Company NameBlue Sail Medical Co.,Ltd.山东前沿医疗器械股份有限公司
Symbol2.38K
MSH IDCN:BLUESAILCN:COM:ZAMT
MarketSTOCKSPRIVATE
SectorHealthcareHealthcare & Health Services
IndustryMedical - Instruments & SuppliesMedical Devices
CountryCNCN
Stage
Employee Count8.09K
Websitebluesail.cnzamt.com.cn
LinkedIn
Founders

Market Metrics

Metric
Market Cap615.89M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Financial Performance

Metric
Revenue680.67M
Revenue (LTM)
Revenue (NTM)
Gross Profit83.73M
EBITDA5.15M
Operating Income-64.93M
Net Income-78.52M
EPS-0.08
Diluted EPS-0.08
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.14
Operating Profit Margin-0.09
EBITDA Margin0.01
Net Profit Margin-0.09
Return on Equity-0.05
Return on Assets-0.03
Return on Capital Employed-0.04

Valuation Multiples

Metric
P/E Ratio-7.61
P/B Ratio0.45
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio1.23
EV Multiple-6.25

Operational Metrics

Metric
Days Sales Outstanding83.23
Days Payables Outstanding39.04
Days Inventory Outstanding90.99
Operating Cycle174.03
Cash Conversion Cycle134.99
Asset Turnover0.35

Cash Flow Metrics

Metric
Operating Cash Flow-10.07M
Free Cash Flow-117.02M
Cash Flow to Debt-0.02
Operating Cash Flow/Sales-0.01
Free Cash Flow Yield-0.23

Balance Sheet Metrics

Metric
Cash & Equivalents177.14M
Accounts Receivable-34.21M
Inventory145.68M
Goodwill535.22M
Debt to Capitalization0.30
Debt to Assets0.23
Current Ratio1.22
Quick Ratio1.15

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue0.07
SG&A to Revenue0.02